ArticleAnnals of vascular diseases2026
A Case of Chronic Expanding Hematoma in the Thoracic Cavity Treated with Transcatheter Arterial Embolization.
Article in Annals of vascular diseases, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Malignant Soft Tissue Tumor Mimicking Chronic Expanding Hematoma After a Long Clinical Course: A Case Report.The American journal of case reports · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Chronic expanding hematoma (CEH) is a rare late complication of thoracic trauma or surgery, and favorable outcomes with transcatheter arterial embolization (TAE) have rarely been reported. An 80-year-old male presented with recurrent hemoptysis and was diagnosed with intrathoracic CEH. Owing to advanced age and high surgical risk, TAE was performed via bronchial, intercostal, and inferior phrenic arteries using tris-acryl microspheres (700-900 μm) and gelatin sponge. Hemoptysis resolved, and follow-up imaging showed hematoma shrinkage without recurrence for 2 years. This case demonstrates TAE with 700-900 μm microspheres as a safe, minimally invasive alternative to surgery for CEH.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.